|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$124,670,210 |
|
|
Indirect Value
|
$39,932,089 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$164,602,299 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-21 |
4 |
B |
$0.61 |
$19,069 |
I/I |
31,128 |
15,715,564 |
2.17 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-22 |
4 |
B |
$0.62 |
$11,895 |
D/D |
19,301 |
15,734,865 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-22 |
4 |
B |
$0.62 |
$23,790 |
I/I |
38,602 |
15,734,865 |
1.5 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-23 |
4 |
B |
$0.62 |
$1,113 |
I/I |
1,800 |
15,735,765 |
1.42 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-23 |
4 |
B |
$0.62 |
$557 |
D/D |
900 |
15,735,765 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-24 |
4 |
B |
$0.70 |
$27,886 |
I/I |
39,888 |
15,755,709 |
1.5 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-24 |
4 |
B |
$0.70 |
$13,943 |
D/D |
19,944 |
15,755,709 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,794,037 |
2.17 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-25 |
4 |
B |
$0.75 |
$28,892 |
D/D |
38,328 |
15,794,037 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-28 |
4 |
B |
$0.73 |
$18,375 |
D/D |
25,321 |
15,819,358 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,819,358 |
2.17 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-29 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,869,358 |
2.17 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-29 |
4 |
B |
$0.72 |
$35,795 |
D/D |
50,000 |
15,869,358 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-30 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,869,870 |
1.42 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-30 |
4 |
B |
$0.74 |
$377 |
D/D |
512 |
15,869,870 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-31 |
4 |
B |
$0.77 |
$19,312 |
D/D |
25,100 |
15,894,970 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-31 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,894,970 |
1.42 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-01 |
4 |
B |
$0.73 |
$10,188 |
D/D |
13,867 |
15,908,837 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-01 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,908,837 |
1.42 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-06 |
4 |
B |
$0.74 |
$1,647 |
D/D |
2,239 |
15,911,076 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,911,076 |
1.42 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-08 |
4 |
B |
$0.75 |
$1,551 |
D/D |
2,060 |
15,913,136 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,913,136 |
1.42 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-09-18 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,919,136 |
2.17 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-09-18 |
4 |
B |
$0.78 |
$4,667 |
D/D |
6,000 |
15,919,136 |
3.84 |
- |
|
790 Records found
|
|
Page 3 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|